BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)
$59.12 -0.85 (-1.4174%)
Analysed BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) News Sources
Biomarin Pharmaceutical (BMRN): Most Undervalued Stocks to Buy and Hold for 2 Years
08-06-2026
yahoo.com
2 Profitable Stocks Worth Your Attention and 1 We Find Risky
11-06-2026
yahoo.com
BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026
16-06-2026
yahoo.com
BioMarin (BMRN) Presents Positive Phase 2 Data for VOXZOGO in Hypochondroplasia Treatment
23-06-2026
yahoo.com
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?
25-06-2026
yahoo.com
Therapeutics Stocks Q1 Teardown: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest
25-06-2026
yahoo.com
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
26-06-2026
yahoo.com
2 Cash-Heavy Stocks with Exciting Potential and 1 We Ignore
29-06-2026
yahoo.com
Collect 9.0% On VRTX Stock Now, And Still Keep 15% Of Upside
08-07-2026
trefis.com
Beyond The Breakout Drug: Is BridgeBio Pharma Stock A Buy On Its Next Act?
10-07-2026
trefis.com
What is the current price of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The current price of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is $59.12.
BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) since the previous trading day is $-0.85.
BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) since the previous trading day is -1.4174%.
What is the most recent average sentiment score for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The most recent average sentiment score for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is 51 out of 100.
What is the most recent average sentiment for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The most recent sentiment for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is .
SEC-8K** Filing Available For BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.